Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU)
Authors:
- Barbara K. BurtonBBBarbara K. Burton
- Lauren LevitonLLLauren Leviton
- 1 October 2010
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 101 (2-3) , 146-148
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Psychiatric symptoms and disorders in phenylketonuria☆Molecular Genetics and Metabolism, 2010
- Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆Molecular Genetics and Metabolism, 2010
- Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuriaProceedings of the National Academy of Sciences, 2008
- Progress toward cell‐directed therapy for phenylketonuriaClinical Genetics, 2008
- Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU)Health and Quality of Life Outcomes, 2008
- Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?Developmental Neuropsychology, 2007
- Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysisMolecular Genetics and Metabolism, 2007
- Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter changeThe Journal of Pediatrics, 1995
- Spasticity and white matter abnormalities in adult phenylketonuria.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of ageJournal of Inherited Metabolic Disease, 1983